News about "Roche"

Roche's Tecentriq Wins US FDA Approval for Stage 3 Colon Cancer

The US FDA has approved Roche’s Tecentriq in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage 3 colon cancer.

Roche | 13/10/2026 | By News Bureau

Roche Reports New Real-World Vabysmo Data Across Retinal Conditions

Roche’s VOYAGER study provides real-world data on Vabysmo’s effectiveness, durability and safety across multiple retinal conditions.

Roche | 03/10/2026 | By News Bureau

Roche's Lunsumio Combo Meets Phase 3 CELESTIMO Endpoint

Roche’s Phase 3 CELESTIMO study shows statistically significant, clinically meaningful improvement in PFS with Lunsumio plus lenalidomide in R/R follicular lymphoma.

Roche | 18/09/2026 | By News Bureau

Roche's Elecsys pTau217 Gets US FDA Clearance for Alzheimer's Assessment

Roche’s Elecsys pTau217 receives US Food and Drug Administration (FDA) clearance as a blood test for Alzheimer’s amyloid pathology assessment across primary and specialty care settings.

Roche | 25/08/2026 | By News Bureau |  102

Roche's Genentech Expands US Manufacturing Operations

Roche’s Genentech expands US manufacturing with a new Hillsboro, Oregon facility for assembling injectable medicines and delivery devices.

Roche | 21/08/2026 | By News Bureau |  107

CHMP Recommends EU Approval of Roche's Susvimo

The Committee for Medicinal Products for Human Use (CHMP) has recommended EU approval of Roche's Susvimo, the first continuous delivery treatment offering an alternative to regular eye injections for wet Age-related Macular Degeneration (AMD).

Roche | 25/07/2026 | By News Bureau |  130

Roche's Gazyva Receives US FDA Priority Review for Membranous Nephropathy

The US Food and Drug Administration (FDA) has granted Priority Review to Roche's Gazyva for primary membranous nephropathy, supported by phase 3 MAJESTY trial results showing superior complete remission versus tacrolimus.

Roche | 17/07/2026 | By News Bureau |  155

Roche Receives CE Mark for Automated Blood Test to Detect Latent Tuberculosis Infection

Roche's Elecsys IGRA TB test enables tuberculosis infection screening with results in under 24 hours, offering faster laboratory workflows and supporting efforts to improve TB diagnosis and control.

Roche | 10/07/2026 | By News Bureau |  186

Roche's Divarasib Outperforms First-Generation KRAS G12C Inhibitors in Phase 3 Lung Cancer Trial

Roche's investigational KRAS G12C inhibitor divarasib demonstrated superior progression-free and overall survival over approved first-generation therapies in the Phase III Krascendo 1 trial, marking a significant advance in the treatment of previously treated KRAS G12C-mutated non-small cell lung cancer.

Roche | 04/07/2026 | By News Bureau |  288

Roche's Divarasib Outperforms KRAS G12C Inhibitors in Phase 3 NSCLC Trial

Roche’s divarasib demonstrated superior Progression-Free Survival over approved KRAS G12C inhibitors in the phase 3 Krascendo-1 trial for previously treated advanced Non-Small Cell Lung Cancer (NSCLC).

Roche | 02/07/2026 | By News Bureau |  166